Michael A. Smith - Jan 7, 2025 Form 4 Insider Report for INSMED Inc (INSM)

Role
Chief Legal Officer
Signature
/s/ Michael A. Smith
Stock symbol
INSM
Transactions as of
Jan 7, 2025
Transactions value $
-$242,816
Form type
4
Date filed
1/10/2025, 06:44 PM
Previous filing
Sep 16, 2024
Next filing
Feb 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Sale -$152K -2.31K -3.39% $65.98 65.6K Jan 7, 2025 Direct F1, F2, F3
transaction INSM Common Stock Sale -$70.4K -1.06K -1.62% $66.21 64.6K Jan 8, 2025 Direct F1
transaction INSM Common Stock Award +5.71K +8.84% 70.3K Jan 8, 2025 Direct F4, F5
transaction INSM Common Stock Sale -$20.2K -319 -0.45% $63.38 70K Jan 10, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Award $0 +27.4K $0.00 27.4K Jan 8, 2025 Common Stock 27.4K $65.72 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.
F2 This is the weighted average sales price representing 2,306 shares sold at prices ranging from $65.96 to $66.04 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3 Includes 92 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F4 Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
F5 Each RSU was granted on January 8, 2025 for no consideration.
F6 These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.